Table 1.
Cell Strain | Average | Avg. % Decrease | |||
---|---|---|---|---|---|
HTM27 | HTM25 | HTM17 | |||
DEX | 100 | 100 | 100 | ||
DEX + 40μM INCA-6 | 43 | 65 | 35 | 48 ± 9% | 52% |
DEX + 80μM INCA-6 | 12 | 27 | 29 | 22 ± 5% | 78% |
DEX + 120μM INCA-6 | 8 | 7 | 22 | 12 ± 5% | 88% |
DEX + 1μM CsA | 29 | 77 | 87 | 64 ± 18% | 36% |
DEX + 10μM CsA | 19 | 34 | 34 | 29 ± 5% | 71% |
Table represents the relative amount of MYOC mRNA levels compared to DEX treatment alone (set to 100%) for individual cell strains tested. Figure 3 shows the average of all 3 cell strains.